Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 4Phase 3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 10fludarabine 5Etoposide 5venetoclax 3Stem Cell Transplantation 3Sirolimus 3Exercise 3Cytarabine 3pembrolizumab 2Vincristine 2Transplantation 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Magnetic Resonance Spectroscopy 2Influenza Vaccines 2Immunotherapy, Adoptive 2Ifosfamide 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Doxorubicin 2Dexamethasone 2Counseling 2Cord Blood Stem Cell Transplantation 2Biopsy 2Azacitidine 2siltuximab 1ruxolitinib 1pirtobrutinib 1nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Spinal Puncture × Other hematologic neoplasm × Clear all
NCT06735690 2026-04-27

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase EARLY_PHASE1 Recruiting
15 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡